Document is current
Any future updates will be listed below
-
Authors
Joachims, Michelle L
Khatri, Bhuwan
Li, Chuang
Tessneer, Kandice L
Ice, John A
Stolarczyk, Anna M
Means, Nicolas
Grundahl, Kiely M
Glenn, Stuart B
Kelly, Jennifer A
Lewis, David M
Radfar, Lida
Stone, Donald U
Guthridge, Joel M
James, Judith A https://orcid.org/0000-0002-9574-7355
Scofield, R Hal
Wiley, Graham B
Wren, Jonathan D
Gaffney, Patrick M https://orcid.org/0000-0002-1580-869X
Montgomery, Courtney G
Sivils, Kathy L
Rasmussen, Astrid https://orcid.org/0000-0001-7744-2948
Farris, A Darise
Adrianto, Indra
Lessard, Christopher J https://orcid.org/0000-0003-2440-3843
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02327884 at ClinicalTrials.govDocuments that mention this clinical trial
Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's disease
https://doi.org/10.1136/ard-2023-224842
Dysregulated long non-coding RNA in Sjögren’s disease impacts both interferon and adaptive immune responses
https://doi.org/10.1136/rmdopen-2022-002672
-
Funding
Funding for this research was provided by:
Presbyterian Health Foundation
Sjögren’s Syndrome Foundation
National Institutes of Health (P20GM103456)
National Institutes of Health (P30AR073750)
National Institutes of Health (P50AR060804)
National Institutes of Health (R01AR065953)
National Institutes of Health (R01AR074310)
National Institutes of Health (R01HL113326)
National Institutes of Health (R21AR079089)
National Institutes of Health (R33AR076803)
National Institutes of Health (U54GM104938)
National Institutes of Health (UM1AI144292)
- License Information
